Evaluation of Necrosis as a Diagnostic and Prognostic Indicator in Adrenocortical Carcinoma

JAMA Surg. 2021 Dec 1;156(12):1173-1174. doi: 10.1001/jamasurg.2021.3646.

Authors

Sarah S Pearlstein¹, Patricia C Conroy¹, Kathryn Chomsky Menut¹, Jina Kim², Claire E Graves³, Robert Ruiz-Cordero⁴, Quan-Yang Duh⁵

Affiliations

¹ Department of Surgery, University of California, San Francisco.
² Inova Schar Cancer Institute, Fairfax, Virginia.
³ Department of Surgery, University of California, Davis.
⁴ Department of Pathology, University of California, San Francisco.
⁵ Section of Endocrine Surgery, Department of Surgery, University of California, San Francisco.

Abstract

This case series examines the presence of necrosis in adrenocortical carcinoma as a diagnostic and prognostic indicator.

MeSH terms

Adrenocortical Carcinoma / pathology*
Adult
Biological Specimen Banks*
California
Female
Humans
Male
Middle Aged
Necrosis / pathology
Prognosis
Staining and Labeling

Grants and funding

T32 CA251070/CA/NCI NIH HHS/United States